DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Virtual Booth

Contact Supplier

Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

INTERMEDIATES

1 Intermediates Suppliers

1 Intermediates Suppliers

Synopsis

ACTIVE PHARMA INGREDIENTS

API Suppliers

USDMF

CEP/COS

JDMF

EU WC

KDMF

NDC API

VMF

Listed Suppliers

API REF. PRICE (USD/KG)

$ 0

MARKET PLACE

API

FDF

1INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

FDF Dossiers

FDA Orange Book

Europe

Canada

Australia

South Africa

Listed Dossiers

0 DRUGS IN DEVELOPMENT

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

EDQM

USP

Others

PATENTS & EXCLUSIVITIES

US Patents

US Exclusivities

Health Canada Patents

DIGITAL CONTENT

Data Compilation #PharmaFlow

Stock Recap #PipelineProspector

Weekly News Recap #Phispers

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid (USD)

Annual Reports (USD Million)

Finished Drug Prices

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown

Click the button for full data set

Also known as: Sam-531, 925448-93-7, Way-262531, Pf-05212365, Cerlapirdine [usan], N,n-dimethyl-3-[(3-naphthalen-1-ylsulfonyl-2h-indazol-5-yl)oxy]propan-1-amine

Molecular Formula

C₂₂H₂₃N₃O₃S

Molecular Weight

409.5 g/mol

InChI Key

NXQGEDVQXVTCDA-UHFFFAOYSA-N

FDA UNII

EK40PJ0V49

Cerlapirdine has been investigated for the treatment of Alzheimer Disease.

1 2D Structure

Cerlapirdine

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

N,N-dimethyl-3-[(3-naphthalen-1-ylsulfonyl-2H-indazol-5-yl)oxy]propan-1-amine

2.1.2 InChI

InChI=1S/C22H23N3O3S/c1-25(2)13-6-14-28-17-11-12-20-19(15-17)22(24-23-20)29(26,27)21-10-5-8-16-7-3-4-9-18(16)21/h3-5,7-12,15H,6,13-14H2,1-2H3,(H,23,24)

2.1.3 InChI Key

NXQGEDVQXVTCDA-UHFFFAOYSA-N

2.1.4 Canonical SMILES

CN(C)CCCOC1=CC2=C(NN=C2C=C1)S(=O)(=O)C3=CC=CC4=CC=CC=C43

2.2 Other Identifiers

2.2.1 UNII

EK40PJ0V49

2.3 Synonyms

2.3.1 MeSH Synonyms

1. Sam-531

2. Way-262531

2.3.2 Depositor-Supplied Synonyms

1. Sam-531

2. 925448-93-7

3. Way-262531

4. Pf-05212365

5. Cerlapirdine [usan]

6. N,n-dimethyl-3-[(3-naphthalen-1-ylsulfonyl-2h-indazol-5-yl)oxy]propan-1-amine

7. Sam-531 Free Base

8. Ek40pj0v49

9. 925448-93-7 (free Base)

10. Cerlapirdine (usan)

11. Way-262,531

12. N,n-dimethyl-3-((3-(naphthalen-1-ylsulfonyl)-2h-indazol-5-yl)oxy)propan-1-amine

13. Cerlapirdine [usan:inn]

14. Unii-ek40pj0v49

15. Sam531

16. Sam 531

17. Pf-5212365

18. Cerlapirdine [inn]

19. Cerlapirdine [who-dd]

20. Gtpl7356

21. Schembl3534330

22. Chembl2103880

23. Schembl21381542

24. Dtxsid201137232

25. Db12229

26. Hy-14431

27. Cs-0003354

28. D10099

29. Q5064514

30. Dimethyl-{3-[3-(naphthalene-1-sulfonyl)-1h-indazol-5-yloxy]-propyl}-amine

31. 1-propanamine, N,n-dimethyl-3-((3-(1-naphthalenylsulfonyl)-1h-indazol-5-yl)oxy)-

32. N,n-dimethyl-3-((3-((naphthalen-1-yl)sulfonyl)-1h-indazol-5-yl)oxy)propan-1-amine

33. N,n-dimethyl-3-((3-(1-naphthylsulfonyl)-1h-indazol-5-yl)oxy)propan-1-amine

34. N,n-dimethyl-3-((3-(naphthalen-1-ylsulfonyl)-1h-indazol-5-yl)oxy)propan-1-amine

2.4 Create Date

2007-06-04

3 Chemical and Physical Properties

Molecular Formula	C₂₂H₂₃N₃O₃S
Molecular Weight	409.5 g/mol
XLogP3	4.3
Hydrogen Bond Donor Count	1
Hydrogen Bond Acceptor Count	5
Rotatable Bond Count	7
Exact Mass	409.14601278 g/mol
Monoisotopic Mass	409.14601278 g/mol
Topological Polar Surface Area	83.7 Å²
Heavy Atom Count	29
Formal Charge	0
Complexity	636
Isotope Atom Count	0
Defined Atom Stereocenter Count	0
Undefined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	1